These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
347 related articles for article (PubMed ID: 31209568)
1. Transplantation of stem cells from umbilical cord blood as therapy for type I diabetes. Stiner R; Alexander M; Liu G; Liao W; Liu Y; Yu J; Pone EJ; Zhao W; Lakey JRT Cell Tissue Res; 2019 Nov; 378(2):155-162. PubMed ID: 31209568 [TBL] [Abstract][Full Text] [Related]
2. Transplantation of differentiated umbilical cord mesenchymal cells under kidney capsule for control of type I diabetes in rat. Moshrefi M; Yari N; Nabipour F; Bazrafshani MR; Nematollahi-mahani SN Tissue Cell; 2015 Aug; 47(4):395-405. PubMed ID: 26025422 [TBL] [Abstract][Full Text] [Related]
3. Transplantation of insulin-producing cells derived from umbilical cord stromal mesenchymal stem cells to treat NOD mice. Wang HS; Shyu JF; Shen WS; Hsu HC; Chi TC; Chen CP; Huang SW; Shyr YM; Tang KT; Chen TH Cell Transplant; 2011; 20(3):455-66. PubMed ID: 20719086 [TBL] [Abstract][Full Text] [Related]
4. Human umbilical cord-derived mesenchymal stem cells can secrete insulin in vitro and in vivo. Boroujeni ZN; Aleyasin A Biotechnol Appl Biochem; 2014; 61(2):82-92. PubMed ID: 23725211 [TBL] [Abstract][Full Text] [Related]
5. Generation of glucose-responsive, insulin-producing cells from human umbilical cord blood-derived mesenchymal stem cells. Prabakar KR; Domínguez-Bendala J; Molano RD; Pileggi A; Villate S; Ricordi C; Inverardi L Cell Transplant; 2012; 21(6):1321-39. PubMed ID: 22195604 [TBL] [Abstract][Full Text] [Related]
6. Differentiation of PDX1 gene-modified human umbilical cord mesenchymal stem cells into insulin-producing cells in vitro. He D; Wang J; Gao Y; Zhang Y Int J Mol Med; 2011 Dec; 28(6):1019-24. PubMed ID: 21837359 [TBL] [Abstract][Full Text] [Related]
7. Making surrogate β-cells from mesenchymal stromal cells: perspectives and future endeavors. Bhonde RR; Sheshadri P; Sharma S; Kumar A Int J Biochem Cell Biol; 2014 Jan; 46():90-102. PubMed ID: 24275096 [TBL] [Abstract][Full Text] [Related]
8. Glucose-stimulated insulin secretion of various mesenchymal stem cells after insulin-producing cell differentiation. Kim SJ; Choi YS; Ko ES; Lim SM; Lee CW; Kim DI J Biosci Bioeng; 2012 Jun; 113(6):771-7. PubMed ID: 22425523 [TBL] [Abstract][Full Text] [Related]
9. Therapeutic Effects of Insulin-Producing Human Umbilical Cord-Derived Mesenchymal Stem Cells in a Type 1 Diabetes Mouse Model. Park YM; Yang CM; Cho HY Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35805883 [TBL] [Abstract][Full Text] [Related]
10. In vitro cultivation of islet-like cell clusters from human umbilical cord blood-derived mesenchymal stem cells. Gao F; Wu DQ; Hu YH; Jin GX; Li GD; Sun TW; Li FJ Transl Res; 2008 Jun; 151(6):293-302. PubMed ID: 18514140 [TBL] [Abstract][Full Text] [Related]
11. Umbilical cord mesenchymal stem cells: adjuvants for human cell transplantation. Friedman R; Betancur M; Boissel L; Tuncer H; Cetrulo C; Klingemann H Biol Blood Marrow Transplant; 2007 Dec; 13(12):1477-86. PubMed ID: 18022578 [TBL] [Abstract][Full Text] [Related]
12. Immune-Modulatory Changes After Transplantation Therapy of Insulin Producing Cells Derived from Wharton's Jelly Human Umbilical Cord-Mesenchymal Stem Cells in Diabetes Induced Rats. Hassanin OM; El-Masry TM; Abu-Zahra FA; El-Adawy S; Abdellah AM Egypt J Immunol; 2019 Jan; 26(1):55-67. PubMed ID: 31332996 [TBL] [Abstract][Full Text] [Related]
13. Wharton's jelly mesenchymal stem cells as candidates for beta cells regeneration: extending the differentiative and immunomodulatory benefits of adult mesenchymal stem cells for the treatment of type 1 diabetes. Anzalone R; Lo Iacono M; Loria T; Di Stefano A; Giannuzzi P; Farina F; La Rocca G Stem Cell Rev Rep; 2011 Jun; 7(2):342-63. PubMed ID: 20972649 [TBL] [Abstract][Full Text] [Related]
14. Laminin 411 acts as a potent inducer of umbilical cord mesenchymal stem cell differentiation into insulin-producing cells. Qu H; Liu X; Ni Y; Jiang Y; Feng X; Xiao J; Guo Y; Kong D; Li A; Li X; Zhuang X; Wang Z; Wang Y; Chang Y; Chen S; Kong F; Zhang X; Zhao S; Sun Y; Xu D; Wang D; Zheng C J Transl Med; 2014 May; 12():135. PubMed ID: 24885418 [TBL] [Abstract][Full Text] [Related]
16. Notch signaling: a novel regulating differentiation mechanism of human umbilical cord blood-derived mesenchymal stem cells into insulin-producing cells in vitro. Hu YH; Wu DQ; Gao F; Li GD; Zhang XC Chin Med J (Engl); 2010 Mar; 123(5):606-14. PubMed ID: 20367990 [TBL] [Abstract][Full Text] [Related]
17. Transplantation of insulin-producing cells to treat diabetic rats after 90% pancreatectomy. Yu YB; Bian JM; Gu DH World J Gastroenterol; 2015 Jun; 21(21):6582-90. PubMed ID: 26074696 [TBL] [Abstract][Full Text] [Related]
18. Treatment of refractory secondary hemophagocytic lymphohistiocytosis with umbilical cord mesenchymal stem cells. Yang X; Zhang S; Huang D; Wang Z; Chen X; Luo X; Lei M; Yu F; Chen X; Huang P J Int Med Res; 2019 May; 47(5):2135-2144. PubMed ID: 30961409 [TBL] [Abstract][Full Text] [Related]
19. Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease. Weiss ML; Medicetty S; Bledsoe AR; Rachakatla RS; Choi M; Merchav S; Luo Y; Rao MS; Velagaleti G; Troyer D Stem Cells; 2006 Mar; 24(3):781-92. PubMed ID: 16223852 [TBL] [Abstract][Full Text] [Related]
20. Mesenchymal Stem Cells: Rising Concerns over Their Application in Treatment of Type One Diabetes Mellitus. Hashemian SJ; Kouhnavard M; Nasli-Esfahani E J Diabetes Res; 2015; 2015():675103. PubMed ID: 26576437 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]